• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Prevalence of Diabetes and Glucose Intolerance in Chronic Hepatitis B Patients at a Tertiary Care Centre in Bihar

    Dr. Narendra Kumar, Dr. Vibha Sushilendu, Dr. Rajeev Kumar, Dr. Satish Kumar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 10788-10793

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: The aim of the study was to compare the prevalence of glucose intolerance in chronic HBV infection.
Materials and Methods: It was a retrospective cohort study conducted in the Department of Medicine, Nalanda Medical College & Hospital, Patna, Bihar, India, during the period of one year. A total of 250 CHB-infected patients who either attended medicine out-patient department or admitted to medicine ward between October 2021 and March 2022 were studied. The diagnosis of CHB was based on the presence of hepatitis B surface antigen positivity for more than 6 months. In all the patients, fasting plasma glucose and postprandial plasma glucose samples were obtained. HbA1C, serum alanine aminotransferase, serum aspartate aminotransferase, and α-fetoprotein were done for all the patients. Hepatitis B e antigen status, HBV DNA, and genotype were determined by a commercially available assay. Fibroscan (transient elastography) is performed in all the patients.
Results: The present study included 250 patients. A majority of patients were in the age group of 21–30 years accounted for 32% and age group of 31– 40 years accounted for 24%. Among the others, 22% were between 11 and 20 years, 16% between 41 and 50 years, and 6% between 51 and 60 years. Gender-wise distribution of male and female was 56% and 44%, respectively. The number of patients with impaired and diabetic range of FBS was 18% and 26%, respectively. Similarly, for PPBS, 65 (26%) patients had impaired range and 95 (38%) patients with diabetic   range. Glycated   hemoglobin   (HbA1C)   value ≥5.7 were present in 165 (66%) patients. The number of patients with fibrosis ≥12.5 kPa was 70; all of them (100%) had FBS ≥110, PPBS ≥140, and HbA1C ≥5.7. The number of genotype C patients was 170, in which 80/170 had FBS ≥110, 115/170 had PPBS ≥140, and 105/170 had HbA1C ≥5.7. The number of patients with genotype D was 80, in which 30/80 had FBS ≥110, 40/80 had PPBS ≥140, and 60/80 had HbA1C ≥5.7.
Conclusion: The prevalence of glucose intolerance was increased in patients with CHB infection. HBV carriers with impaired glucose tolerance are at high risk for end-stage liver disease, and therefore HBV carriers should be considered for surveillance programs that closely monitor liver enzymes and lipid profile and detect changes in ALT and TG levels.
Keywords:
  • PDF (148 K)
  • XML
(2022). Prevalence of Diabetes and Glucose Intolerance in Chronic Hepatitis B Patients at a Tertiary Care Centre in Bihar. European Journal of Molecular & Clinical Medicine, 9(3), 10788-10793.
Dr. Narendra Kumar, Dr. Vibha Sushilendu, Dr. Rajeev Kumar, Dr. Satish Kumar. "Prevalence of Diabetes and Glucose Intolerance in Chronic Hepatitis B Patients at a Tertiary Care Centre in Bihar". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 10788-10793.
(2022). 'Prevalence of Diabetes and Glucose Intolerance in Chronic Hepatitis B Patients at a Tertiary Care Centre in Bihar', European Journal of Molecular & Clinical Medicine, 9(3), pp. 10788-10793.
Prevalence of Diabetes and Glucose Intolerance in Chronic Hepatitis B Patients at a Tertiary Care Centre in Bihar. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 10788-10793.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 45
  • PDF Download: 62
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus